Eleni Aklillu Selected Research

Infections

12/2021	Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts.
1/2021	Effect of Pharmacogenetics Variations on Praziquantel Plasma Concentrations and Schistosomiasis Treatment Outcomes Among Infected School-Aged Children in Tanzania.
12/2020	Prevalence, Intensity, and Correlates of Soil-Transmitted Helminth Infections among School Children after a Decade of Preventive Chemotherapy in Western Rwanda.
11/2020	Prevalence, Intensity, and Correlates of Schistosomiasis and Soil-Transmitted Helminth Infections after Five Rounds of Preventive Chemotherapy among School Children in Southern Ethiopia.
5/2020	Prevalence and Correlates of Lymphatic Filariasis Infection and Its Morbidity Following Mass Ivermectin and Albendazole Administration in Mkinga District, North-Eastern Tanzania.
1/2017	Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women.
10/2012	β-defensin genomic copy number is associated with HIV load and immune reconstitution in sub-saharan Africans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eleni Aklillu Research Topics

Disease

20	Tuberculosis (Tuberculoses) 03/2022 - 03/2008
11	Coinfection 11/2022 - 03/2008
11	Malaria 12/2021 - 04/2015
7	Schistosomiasis (Bilharziasis) 01/2022 - 12/2019
7	Infections 12/2021 - 10/2012
6	Body Weight (Weight, Body) 12/2019 - 05/2010
4	Schistosomiasis mansoni 04/2021 - 12/2019
4	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2019
4	Chemical and Drug Induced Liver Injury 01/2017 - 01/2011
3	Filarial Elephantiasis (Lymphatic Filariasis) 05/2022 - 05/2020
3	COVID-19 03/2022 - 12/2021
3	Pregnancy Complications 12/2021 - 07/2019
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2021 - 06/2019
2	HIV Infections (HIV Infection) 01/2021 - 06/2013
2	Schizophrenia (Dementia Praecox) 01/2020 - 05/2010
2	Anemia 01/2020 - 01/2019
2	Vitamin D Deficiency 01/2019 - 08/2016
2	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2017 - 01/2016
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2015 - 08/2011
2	Lung Neoplasms (Lung Cancer) 03/2013 - 06/2005
2	Hepatocellular Carcinoma (Hepatoma) 06/2009 - 09/2003
2	Neoplasms (Cancer) 06/2005 - 03/2002
1	Communicable Diseases (Infectious Diseases) 03/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 03/2022
1	Glucose Metabolism Disorders 01/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Neglected Diseases 05/2020
1	Overweight 03/2020
1	Fever (Fevers) 02/2020
1	Dyslipidemias (Dyslipidemia) 03/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Neutropenia 01/2019
1	Inflammation (Inflammations) 01/2017
1	Immune Reconstitution Inflammatory Syndrome 01/2015
1	Sleep Initiation and Maintenance Disorders (Insomnia) 06/2013
1	Hallucinations (Hallucination) 06/2013
1	Sleep Wake Disorders 06/2013

Drug/Important Bio-Agent (IBA)

15	efavirenz (Sustiva)FDA Link 01/2022 - 01/2011
11	Rifampin (Rifampicin)FDA LinkGeneric 11/2022 - 01/2011
9	Pharmaceutical PreparationsIBA 01/2022 - 03/2008
9	EnzymesIBA 01/2022 - 03/2002
7	Praziquantel (Biltricide)FDA Link 01/2022 - 12/2019
6	Cytochrome P-450 CYP3AIBA 01/2021 - 08/2011
6	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 02/2020 - 04/2015
5	Lumefantrine FDA Link 02/2020 - 04/2015
4	Albendazole (Albenza)FDA Link 05/2022 - 05/2020
4	pyrimethamine drug combination fanasil (Fansidar)FDA Link 12/2021 - 07/2019
4	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 11/2018 - 06/2013
4	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 03/2013 - 09/2003
3	VaccinesIBA 03/2022 - 12/2021
3	artenimol (dihydroartemisinin)IBA 12/2021 - 01/2020
3	piperaquineIBA 12/2021 - 01/2020
2	Ivermectin (Mectizan)FDA Link 05/2022 - 05/2020
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 01/2019
2	Olanzapine (Zyprexa)FDA Link 01/2020 - 05/2010
2	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 09/2019 - 11/2007
2	Tamoxifen FDA LinkGeneric 09/2019 - 01/2019
2	Antimalarials (Antimalarial Agents)IBA 04/2019 - 04/2015
2	CholesterolIBA 03/2019 - 08/2016
2	Vitamin D FDA LinkGeneric 01/2019 - 08/2016
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2017 - 03/2014
2	Antitubercular AgentsIBA 09/2016 - 01/2012
2	Biomarkers (Surrogate Marker)IBA 03/2014 - 01/2011
2	Alanine Transaminase (SGPT)IBA 03/2014 - 08/2011
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 08/2011 - 06/2005
2	Antipsychotic Agents (Antipsychotics)IBA 11/2007 - 02/2006
1	NucleotidesIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	rifapentine (Priftin)FDA Link 01/2022
1	RifamycinsIBA 01/2022
1	Atazanavir Sulfate (Reyataz)FDA Link 01/2022
1	Ritonavir (Norvir)FDA Link 01/2022
1	Diethylcarbamazine (Hetrazan)FDA Link 03/2021
1	Moxifloxacin (Avelox)FDA Link 01/2021
1	Levofloxacin (Levaquin)FDA Link 01/2021
1	Warfarin (Coumadin)FDA LinkGeneric 03/2020
1	Coffee FDA Link 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	4-hydroxy-N-desmethyltamoxifenIBA 09/2019
1	Triglycerides (Triacylglycerol)IBA 03/2019
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2019
1	HLA-B57 antigenIBA 01/2017
1	Floxacillin (Flucloxacillin)IBA 01/2017
1	8-hydroxyefavirenzIBA 12/2016
1	hydroxide ionIBA 08/2016
1	Cytochrome P-450 CYP2C9IBA 06/2015
1	Nevirapine (Viramune)FDA Link 04/2015
1	RNA (Ribonucleic Acid)IBA 01/2015
1	ImmunosorbentsIBA 03/2014
1	Keratin-18 (Keratin 18)IBA 03/2014
1	Complement System Proteins (Complement)IBA 03/2014
1	Caffeine (No Doz)FDA LinkGeneric 03/2013

Therapy/Procedure

22	Therapeutics 11/2022 - 02/2006
11	Drug Therapy (Chemotherapy) 05/2022 - 02/2006
9	Highly Active Antiretroviral Therapy (HAART) 01/2022 - 01/2012
3	Mass Drug Administration 05/2022 - 01/2020
2	Prenatal Care (Care, Prenatal) 03/2020 - 01/2020
1	Precision Medicine 03/2022
1	Aftercare (After-Treatment) 01/2017
1	Art Therapy 04/2015